A carregar...
Assessment and Development of the Antifungal Agent Caspofungin for Aerosolized Pulmonary Delivery
Invasive Pulmonary Aspergillosis (IPA) and Pneumocystis jiroveci Pneumonia (PCP) are serious fungal pulmonary diseases for immunocompromised patients. The brand name drug CANCIDAS(®) (Caspofungin acetate for injection) is FDA approved to treat IPA, but is only 40% effective. Efficacious drug levels...
Na minha lista:
| Publicado no: | Pharmaceutics |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8067632/ https://ncbi.nlm.nih.gov/pubmed/33916988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13040504 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|